Filing Details

Accession Number:
0000899243-15-008898
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-25 16:05:28
Reporting Period:
2015-11-23
Filing Date:
2015-11-25
Accepted Time:
2015-11-25 16:05:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1285819 Omeros Corp OMER Pharmaceutical Preparations (2834) 911663741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472163 S. Marcia Kelbon 201 Elliott Avenue West
Seattle WA 98119
Vp Patent And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-23 15,900 $0.98 147,026 No 4 M Direct
Common Stock Disposition 2015-11-23 15,900 $15.00 131,126 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-11-23 15,900 $0.00 15,900 $0.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
159,100 2016-12-11 No 4 M Direct
Footnotes
  1. Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person on June 3, 2014, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established, in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This Rule 10b5-1 plan provides for fixed sales of a total of 175,000 shares, by exercise of options otherwise expiring on December 11, 2016, over a one-year period beginning in November 2015, with sale periods commencing approximately monthly and with approximately 15,900 shares to be sold in each sale period. Proceeds will be used for the payment of taxes owed on options exercised and held earlier this year and may also be used to fund the costs of and taxes on the future exercise and holding of other options. This sale of 15,900 shares is the result of the first monthly trade pursuant to this trading plan.
  2. The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on November 1, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter.